CSIMarket Company Name, Ticker, Competitors, else..
 
Checkpoint Therapeutics inc   (NASDAQ: CKPT)
 

CKPT's Market share relative to its competitors, as of Q1 2025

As of Q1 2025 (Revenue in Millions of $)

Date modified: 2026-09-01T06:12:10+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months
Q1 2025		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE
A Quarter Before
Q4 2024
Checkpoint Therapeutics inc 0.36 0.00% 0.00 % 0.00 %
Eli Lilly And Company 72,249.50 48.23% 26.50% 25.29%
Novartis Ag 51,722.00 34.52% 65.36% 66.08%
Regeneron Pharmaceuticals Inc 14,919.60 9.96% 4.16% 4.96%
Beone Medicines Ltd 5,738.44 3.83% 1.97% 1.93%
Madrigal Pharmaceuticals Inc 1,132.49 0.76% 0.42% 0.40%
54 more competitors available

Sign in to see all competitors for Checkpoint Therapeutics inc .

Sign In Create Free Account



CKPT's Market share relative to its competitors, as of Q1 2025 within the Major Pharmaceutical Preparations Industry
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Checkpoint Therapeutics inc 0.00% 0.00% 0.00 % 0.00 %
Eli Lilly And Company 48.36% 47.86% 26.54% 25.33%
Novartis Ag 34.62% 34.26% 65.46% 66.17%
Regeneron Pharmaceuticals Inc 9.99% 10.53% 4.16% 4.97%
Beone Medicines Ltd 3.84% 3.92% 1.97% 1.94%
Madrigal Pharmaceuticals Inc 0.76% 0.70% 0.42% 0.40%
52 more companies available

Sign in to see all industry competitors for Checkpoint Therapeutics inc .

Sign In Create Free Account



CKPT's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2025		 MARKET SHARE
12 Months Ending
Q4 2024		 MARKET SHARE
MRQ
Q1 2025		 MARKET SHARE

Q4 2024
Checkpoint Therapeutics inc 0.00% 0.00% 0.00 % 0.00 %
Eli Lilly And Company 48.23% 47.73% 26.50% 25.29%
Novartis Ag 34.52% 34.17% 65.36% 66.08%
Regeneron Pharmaceuticals Inc 9.96% 10.50% 4.16% 4.96%
Beone Medicines Ltd 3.83% 3.91% 1.97% 1.93%
Madrigal Pharmaceuticals Inc 0.76% 0.70% 0.42% 0.40%
54 more companies available

Sign in to see all sector competitors for Checkpoint Therapeutics inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Checkpoint Therapeutics inc's market divisions, geographic dispersion, segments, products, and services, visit Checkpoint Therapeutics inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.